Shareholders meeting

August 14, 2026 To, To, Listing Department, The National Stock Exchange of India BSE Limited Ltd. Phiroze Jeejeebhoy Towers, The Listing Department Dalal Street, Exchange Plaza, Mumbai – 400 001 Bandra – Kurla Complex, Ref: BSE Scrip Code: 544497 Mumbai – 400051, NSE Scrip Code: AHCL Dear Sir/ Madam, Sub: Notice of the 13th (Thirteenth) Annual General Meeting (“AGM”) of Anlon Healthcare Limited along with Annual Report for the Financial Year 2025-26. In terms of requirements of Regulation 30 of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirement) Regulation, 2015, please find enclosed herewith Notice of 13th Annual General Meeting of the Company for the financial year 2025-2026. The Company has sent the same through electronic mode to the members who have registered their E-Mail IDs with the Company’s RTA/Depository Participants. The 13th AGM will be held on Saturday, September 05, 2026, at 11:00 a.m. IST through video conference and other audio-visual means (VC). Further, the aforesaid Notice of AGM has also been uploaded on the website of the Company at www.anlon.in. Kindly take the same on your record. Thanking You. For ANLON HEALTHCARE LIMITED PUNITKUMAR RASADIA MANAGING DIRECTOR DIN: 06696258 Enclosed: Notice of 13th AGM ANLON HEALTHCARE LIMITED CIN No.: L24230GJ2013PLC077543 REGISTERED OFFICE: 101/102, Silver Coin Complex, Opp. Crystal Mall, Kalawad Road, Rajkot- 360005, Gujarat (INDIA) PHONE NO.: +91-7069690081/82 | Email: info@anlonhealthcare.com | www.anlon.in NOTICE NOTICE is hereby given that the 13th Annual General Meeting of the members of ANLON HEALTHCARE LIMITED will be held on Saturday, September 05, 2026 at 11:00 a.m. IST through Video Conferencing (‘VC’) / Other Audio Visual Means (‘OAVM’) to transact the following business: ORDINARY BUSINESS: ITEM 1 TO RECEIVE, CONSIDER AND ADOPT THE AUDITED STANDALONE FINANCIAL STATEMENTS OF THE COMPANY FOR THE FINANCIAL YEAR ENDED MARCH 31, 2026 TOGETHER WITH THE REPORTS OF THE BOARD OF DIRECTORS AND AUDITORS THEREON. To consider and if thought fit, to pass, with or without modification(s), the following resolution as an Ordinary Resolution: “RESOLVED THAT the audited standalone financial statement of the Company for the financial year ended March 31, 2026 and the reports of the Board of Directors and Auditors thereon, as circulated to the members, be and are hereby considered and adopted.” ITEM 2 TO RECEIVE, CONSIDER AND ADOPT THE AUDITED CONSOLIDATED FINANCIAL STATEMENTS OF THE COMPANY FOR THE FINANCIAL YEAR ENDED MARCH 31, 2026 TOGETHER WITH THE REPORTS OF THE BOARD OF DIRECTORS AND AUDITORS THEREON. To consider and if thought fit, to pass, with or without modification(s), the following resolution as an Ordinary Resolution: “RESOLVED THAT the audited consolidated financial statement of the Company for the financial year ended March 31, 2026 and the reports of the Board of Directors and Auditors thereon, as circulated to the members, be and are hereby considered and adopted.” ITEM 3 TO APPOINT A DIRECTOR IN PLACE OF MR. PUNITKUMAR RAMESHBHAI RASADIA (DIN: 06696258) WHO RETIRES BY ROTATION AND BEING ELIGIBLE, OFFERS HIMSELF FOR RE- APPOINTMENT. To consider and if thought fit, to pass, with or without modification(s), the following resolution as an Ordinary Resolution: “RESOLVED THAT in accordance with the provisions of Section 152 and other applicable provisions of the Companies Act, 2013, Mr. Punitkumar Rameshbhai Rasadia (DIN: 06696258), who retires by rotation at this meeting be and is hereby appointed as a Director of the Company.” Anlon Healthcare Limited - Annual Report - 2025-26 08 SPECIAL BUSINESS ITEM 4 TO APPOINT MR. KISHAN VINODKUMAR RAJA (DIN: 11522235) AS A NON-EXECUTIVE & INDEPENDENT DIRECTOR: To consider and if thought fit, to pass, with or without modification(s), the following resolution as an Ordinary Resolution: “RESOLVED THAT pursuant to the provisions of Sections 149, 150, 152 read with Schedule IV and other applicable provisions of the Companies Act, 2013 (“the Act”) and the Rules made thereunder (including any statutory modification(s) or re-enactment(s) thereof, for the time being in force), Mr. Kishan Vinodkumar Raja (DIN: 11522235), who was appointed as an additional director (Independent Director) of the Company by the Board of the Directors of the Company w.e.f. February 09, 2026 pursuant to the Provisions of Section 161(1) of the Act and the Articles of Association of the Company and in respect of whom the Company has received a declaration that he meets the criteria for independence as provided under in the Companies Act, 2013 and in respect of whom the Company has received a notice in writing from a Member under Section 160 of the Companies Act, 2013 proposing the candidature of Mr. Kishan Vinodkumar Raja (DIN: 11522235) for the office of Independent Director, be and is hereby appointed as a Non-Executive & Independent Director of the Company, not liable to retire by rotation, for a term of five consecutive years commencing from February 09, 2026. RESOLVED FURTHER THAT the Board of Directors of the Company be and is hereby authorized to do all such acts, deeds, matters and things as may be considered necessary, desirable and expedient for giving effect to this resolution and/or otherwise considered by them in the best interest of the Company.” ITEM 5 TO APPROVE REMUNERATION OF COST AUDITOR OF THE COMPANY: To consider and if thought fit, to pass with or without modification(s), the following Resolution as an Ordinary Resolution: “RESOLVED THAT pursuant to the provisions of Section 148 and other applicable provisions, if any, of the Companies Act, 2013, the Companies (Audit and Auditors) Rules, 2014 (including any statutory modification(s) or re-enactment(s) thereof for the time being in force), and such other permissions as may be necessary, the payment of the total remuneration of Rs.45,000/- plus reimbursement of out-of-pocket expenses at actual plus applicable taxes payable to M/s M. C. Bambhroliya & Associates, Cost Accountants, who were appointed as “Cost Auditor” to conduct the audit of Cost Records maintained by the Company for the Financial Year ending March 31, 2027, be and is hereby ratified and approved. RESOLVED FURTHER THAT the Board or any duly constituted Committee of the Board, be and is hereby authorized to do all acts, deeds, matters and things as may be deemed necessary and/or expedient in connection therewith or incidental thereto, to give effect to the foregoing resolution.” Anlon Healthcare Limited - Annual Report - 2025-26 09 ITEM 6 ENHANCEMENT OF AUTHORISED SHARE CAPITAL: To consider and if thought fit, to pass with or without modification(s), the following resolutions as an Ordinary Resolution: “RESOLVED THAT pursuant to the provisions of Section 61 and 64 and other applicable provisions, if any, of the Companies Act, 2013 (including any amendment thereto or re-enactment thereof) and the rules framed there under, the Authorized Share Capital of the Company be and is hereby authorized to be increased from Rs.1,100,000,000/- (Rupees One Hundred and Ten Crore Only) divided into 550,000,000 (Fifty Five Crore) Equity Shares of Rs.02/- each to Rs.1,300,000,000 (Rupees One Hundred and Thirty Crore Only) divided into 650,000,000 (Sixty Five Crore) Equity Shares of Rs.02/- each by creation of additional 100,000,000 (Ten Crore) Equity Shares of Rs.02/- each ranking pari passu in all respect with the existing Equity Shares. RESOLVED FURTHER THAT board of directors of the company be and is hereby authorized to do all such acts, deeds, matters and things as may be considered necessary, desirable and expedient for giving effect to this resolution and/or otherwise considered by them in the best interest of the Company.” ITEM 7 ALTERATION OF CAPITAL CLAUSE CONTAINED IN THE MEMORANDUM OF ASSOCIATION: To consider and if thought fit, to pass with or without modification, the following resolution as a Special Resolutio [Showing first 8,000 characters — download PDF for full document]